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Abstract
Background: Leprosy is a chronic disease, caused by Mycobacterium leprae, which poses a serious public health problem
worldwide. Its high incidence in people under 15 years old in Ceara´ state, Brazil, reflects the difficulty of its control. The
spectrum of clinical manifestations is associated with the immune response developed, with the Th1 and Th2 responses
being related to the paucibacillary and multibacillary forms, respectively. Regulatory T cells (Treg), which can suppress Th1
and Th2 response, have received special attention in the literature and have been associated with development of chronic
infections. However, their role in leprosy in individuals under 15 years old has not yet been elucidated. We evaluated the
frequency of CD4+/CD8+CD25highFOXP3+ and CD4+/CD8+CD25highFOXP3high cells in leprosy patients and household
contacts, in both cases under 15 years old.
Methodology/Principal Findings: PBMC from 12 patients and 17 contacts were cultured for 72 hours with anti-CD3 and
anti-CD28 (activators) or with activators associated with total sonicated fraction of M. leprae. After culture, the frequency of
CD4+/CD8+ Treg was identified by flow cytometry. Cells stimulated by activators and antigen from multibacillary patients
showed Treg frequencies almost two times that of the contacts: CD4+FOXP3+ (21.9368.43 vs. 13.7968.19%, p = 0.0500),
CD4+FOXP3high (10.3365.69 vs. 5.5764.03%, p = 0.0362), CD8+FOXP3+ (13.8869.19 vs. 6.1865.56%, p = 0.0230) and
CD8+FOXP3high (5.3664.17 vs. 2.2362.68%, p = 0.0461). Furthermore, the mean fluorescence intensity of FOXP3 in Treg was
higher in multibacillary patients than in the contacts. Interestingly, there was a positive correlation of the bacillary index and
number of lesions with the frequency of all Treg evaluated in patients.
Conclusions/Significance: We have demonstrated for the first time that multibacillary leprosy patients under 15 years old
have greater CD4+ and CD8+ Treg frequencies and these correlate with clinical and laboratorial aspects of disease. These
findings suggest the involvement of these cells in the perpetuation of M. leprae infection.
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Introduction
Leprosy is a chronic disease caused by Mycobacterium leprae. It is
characterized by skin lesions with changes in sensitivity and neural
damage, with possible incapacitation and deformities. The disease
is an important public health problem worldwide [1], especially in
Ceara´ state, in Brazil, where it is endemic. This state occupies the
13th place in Brazil and 4th place in the Northeast Brazilian
region in new case detection rate for leprosy [2].
The disease’s incidence among individuals under 15 years old is
an important epidemiological indicator, because it is directly
related to active transmission foci in the community [3]. The new
case detection rate in this age group in Ceara´ state is high, 5.3
cases/100,000 inhabitants in 2012. In addition to the high number
of cases, delayed diagnosis in the region influences the high
number of people with disabilities and deformities resulting from
the disease [2].
The household contacts (HHC) of leprosy patients have a high
risk of acquiring the disease, which is influenced by the contact age
and gender, presence of a BCG vaccination scar and the clinical
form of the index case. Among children and adolescents, this risk
increases in the age range of 10 to 19 years [4].
For treatment purposes, the Brazilian Ministry of Health and
the World Health Organization classify leprosy into two forms:
paucibacillary (PB) and multibacillary (MB), according to the
number of lesions, degree of neural compromise and/or bacillo-
scopy result. The PB form is characterized by the presence of up to
five characteristic lesions, negative bacilloscopy and no nerve
affected, whereas the MB form has more than five lesions and/or
positive bacilloscopy and/or at least one nerve trunk compromised
[5].
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The majority of individuals infected by M. leprae do not get sick,
with only a small portion developing clinical manifestations [6].
This makes the disease even more intriguing, and raises questions
about the factors responsible for the greater susceptibility of some
Figure 1. Representative FACS plots of CD4+/CD8+ Treg frequencies in contacts and leprosy patients. The frequency of Treg in CD4+ (A,
C and E) or CD8+ (B, D and F) lymphocyte gate after 72-hour culture of peripheral blood mononuclear cells with anti-CD3 and anti-CD28 associated
with total sonicated fraction of M. leprae. Identification of CD4+/CD8+CD25highFOXP3+ (dotted line) and CD4+/CD8+CD25highFOXP3high (solid line) cells
in household contact (HHC) of leprosy patient (A and B), paucibacillary (PB) patient (C and D) and multibacillary (MB) patient (E and F). Numbers
represent percentages of events within each Treg gate in the total CD4+/CD8+ lymphocyte population.
doi:10.1371/journal.pone.0079072.g001
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people. The balance between Th1 and Th2 responses was for a
long time utilized to explain the clinical forms of the disease and
the susceptibility to getting sick, since the spectrum of clinical
manifestations is related to the immunological response pattern of
the host. The cell-mediated immune response characterizes the PB
form, with a predominance of Th1 cytokines, limitation of
bacillary proliferation and relative resistance to the pathogen,
while the lack of Th1 response and predominance of Th2 response
characterizes the MB form, which has intense bacillary multipli-
cation [7].
However, the development of the immune response, which
controls the growth of the pathogen and limits the tissue lesion
caused by an exacerbated response, is important for the resolution
of the infection [8]. The response mediated by regulatory T cells
(Treg) has been related to infection susceptibility [9], since it can
promote the growth and persistence of the pathogens [10]. Hence,
these cells have gained importance in understanding the immu-
nopathogenesis of leprosy, bringing into question the paradigm of
Th1 and Th2 response, as suggested by Kumar et al. by analyzing
the profile of various genes in leprosy patients. In multibacillary
patients they found down-regulation of genes related to Th1 and
Th2 immune response and up-regulation of those related to Th3
immune response, which is mediated by Treg cells, with increased
levels of TGF-b as a favorable factor for growth and survival of
M. leprae [11].
Treg comprise about 1–2% of CD4+ T lymphocytes in human
peripheral blood [12] and can suppress a wide range of immune
cells, being important for maintaining homeostasis [13]. In
humans they are heterogeneous populations that can be charac-
terized by expression of FOXP3 (Forkhead box P3) and by high
expression of CD25 (Interleukin-2 receptor a-chain) [14]. The
CD4+CD25highFOXP3+ Treg population has been more exten-
sively studied, but according to Miyara et al., this conventional
subset of Treg can be divided into different fractions according to
the expression of FOXP3. In human peripheral blood, the fraction
CD4+CD25highFOXP3high is composed of activated Treg, which
have higher suppressor capacity in vitro [15]. In fact, expression of
Foxp3, a main control gene of Treg responsible for their
development and function, is critical for its regulatory function
[14].
Although CD8+ Treg have received less attention in the
literature [16], the existence of CD8+ Treg is now well established,
which can expand after stimulation with different antigens [17].
CD8+ Treg, isolated from healthy humans, express CD25 and
FOXP3, produce IL-10 and are functionally suppressive when
stimulated in vitro [18]. CD8+CD25highFOXP3+ cells also have
been investigated in humans and demonstrated suppressive
capacity in vitro [19]. In leprosy, the first cells with suppressive
activity were characterized by the expression of the CD8 molecule
[20,21] and were associated with hyporesponsiveness in leproma-
tous patients [22], but the CD8+ Treg frequency and their relation
to leprosy’s clinical forms has not yet been demonstrated.
Although the role of Treg in M. leprae infection is not clearly
elucidated, the importance of these cells in the perpetuation of
chronic infections has been demonstrated in infections by other
intracellular microorganisms. In mice infected with Mycobacterium
tuberculosis antigen-specific CD4+CD25+ Treg were capable of
preventing the expansion and mobilization of effector T cells to
the infection site, promoting the survival of the microorganism
[23]. Hisaeda et al. demonstrated that the depletion of CD25+
cells protects mice from death due to infection by the lethal strain
of Plasmodium yoelii [24]. The depletion of Treg reduces the
bacterial load in lungs of mice infected with Mycobacterium
tuberculosis [25].
In this study, we evaluated for the first time the frequency of
CD4+ and CD8+ Treg in leprosy patients and HHC, in both cases
under 15 years old, and their relation with the clinical forms of the
disease, to shed light on their role in the pathogenesis of the disease
in this age group. Studies in this age group can help identify factors
that influence the development of the disease and can be used in
early diagnosis.
Methods
Ethics Statement
This study was approved by the ethics committee of Federal
University of Ceara´ under protocol number 161/11. All legal
guardians signed the informed consent form.
Characterization of Patients and HHC
Patients and HHC were seen in the period of March to June of
2012, in the Centro de Dermatologia Sanita´ria Dona Libaˆnia, a
reference center for the diagnosis and treatment of leprosy in
Ceara´ state, Brazil. HHC were defined as those who lived with the
index case at diagnosis. All participants had been vaccinated at
birth with BCG, evidenced by the presence of the vaccination scar
and/or vaccination registration card from the Ministry of Health.
A dermatological-neurological examination of HHC was carried
out by professionals of the reference center to rule out the presence
of the disease. None of patients and HHC were on immunosup-
pressive therapy or had associated comorbidities. The patients
included had clinical and laboratory diagnosis of leprosy and we
excluded those with type 1 or 2 reaction. After authorization from
the legal guardian and signed informed consent, a questionnaire
was filled out to obtain information regarding identification, BCG
vaccination, physical examination and laboratory tests of the
patient or HHC and of their index case, and 10 mL of peripheral
venous blood was collected by a trained professional. The blood
sample for peripheral blood mononuclear cell (PBMC) culture and
flow cytometry was transported refrigerated within 4 h of drawing
the blood sample.
Twenty-nine individuals were evaluated, including 12 untreated
patients and 17 HHC. Among the 12 patients who participated in
the study, there were 5 females and 7 males, and the median age
was 12 years (range 5 to 15 years). Six patients had the MB form
and the other 6 had the PB form. Among the 17 HHC, there were
11 males and 6 females, with a median age of 5 years (range 1 to
14 years), and 8 individuals were contacts of MB patients and 9 of
PB patients. The median time of treatment of the index case in the
HHC group was 14 days (range 1 to 37 days). The contacts had
adults as index cases, with the exception of two who were contacts
of two individuals under 15 years who participated in the survey.
Stimulation of PBMC
The culture of PBMC was adapted from that described by
Spencer et al. [26]. PBMC were obtained by separation in a Ficoll
gradient (GE Healthcare, USA), and the concentration was
adjusted to 2.56106 cells/mL in AIM-V culture medium
(GIBCO, USA). PBMC samples from patients and contacts were
stimulated with anti-CD3 antibodies (UCHT1, BD Biosciences,
USA) and anti-CD28 antibodies (CD28.2, BD Biosciences) [27],
both soluble and at a concentration of 0.5 mg/mL, or with anti-
CD3 and anti-CD28 antibodies combined with the total sonicated
fraction of M. leprae (MLT), at a concentration of 20 mg/mL. The
cell suspension was distributed, in duplicate, in a 96-well plate (BD
Biosciences) and cultivated in a 5% CO2 humidified atmosphere
for 72 h at 37uC.
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Reagents for Characterization of Treg
The anti-FOXP3 PE (259D/C7, BD Biosciences) was chosen
because of the good separation between FOXP32 and FOXP3+
cells and lower nonspecific binding [28], besides its good stability
in the detection of FOXP3 in cells stimulated with anti-CD3 and
anti-CD28 after several days of culture [29]. The antibodies anti-
CD25 FITC (M-A251, BD Biosciences), anti-CD4 PerCP-Cy5.5
(RPA-T4, Ebioscience, USA), anti-CD8 PerCP-Cy5.5 (RPA-T8,
Ebioscience), anti-CD8 APC (RPA-T8, BD Biosciences) and anti-
CD3 APC (OKT.3, BioLegend or Ebiosciences, USA) were
titered, as well as anti-FOXP3, where the best concentration was
chosen based on the highest percentage of positive cells and mean
fluorescence intensity (MFI). The human FOXP3 buffer set from
BD Biosciences was used for fixation and permeabilization.
Preparation of Cells for Flow Cytometry
After culture, 2 mM of ethylenediamine tetraacetic acid was
added to dislodge the adherent cells. The cells were labeled with
surface antibodies for 30 min at 21uC in the dark. Intracellular
labeling of FOXP3 was performed according to the specifications
of the manufacturer. The cells were fixed in 1% paraformaldehyde
and stored at 4uC. Flow cytometry was carried out within 24 h of
cell preparation.
Data Acquisition and Analyses
The data were collected using a FACSCalibur flow cytometer
(BD Biosciences), with measurement of up to 400,000 events per
sample in the lymphocyte gate. The results were analyzed with the
FlowJo program (version 7.6.5; Treestar US, Ashland, OR).
Statistical Analysis
The data were analyzed using the GraphPad Prism version 5
statistical program. The unpaired two-tailed t-test was used to
determine differences between two variables and Pearson’s test
was used for correlation analyses. Results were expressed as mean
and standard deviation and p#0.05 was considered significant.
Results
Gating Strategy for Identification of Treg
Representative FACS plots of CD4+ and CD8+ Treg frequen-
cies in HHC, PB and MB patients are shown in Figure 1. Positivity
for CD25 and for FOXP3 was defined in each individual based on
isotypic controls. CD25high was defined by fluorescence intensity
above 102. Among the CD25highFOXP3+ population, we observed
a distinct population of FOXP3high cells, which we defined as
CD25highFOXP3high cells. We adjusted the gate of the FOXP3high
cells for each individual and the cut-off for FOXP3high intensity
ranged from 3.102 to 7.102. The results of anti-CD3, anti-CD28
and MLT stimulated cells showed the same differences between
groups that were observed with activators only. We decided to
show the results that include the specific stimulus of M. leprae.
Treg Frequency Differs between Patients and Contacts
Initially, we evaluated CD4+ and CD8+CD25highFOXP3+ Treg
frequencies. There were no differences in these Treg frequencies
in leprosy patients versus HHC (CD4+ Treg, 18.7066.77 vs.
13.7968.19%, p = 0.0996 and CD8+ Treg, 10.2967.57 vs.
6.1865.56%, p = 0.1033, data not shown). When patients were
Figure 2. The frequency of CD4+/CD8+CD25highFOXP3+ cells and FOXP3 mean fluorescence intensity (MFI) in leprosy patients and
contacts. The frequency of Treg in CD4+ or CD8+ lymphocyte gate after 72-hour culture of peripheral blood mononuclear cells with anti-CD3 and
anti-CD28 associated with total sonicated fraction of M. leprae. Comparison between household contacts (HHC), multibacillary patients (MB P) and
paucibacillary patients (PB P), with regard to frequency of CD4+CD25highFOXP3+ (A) and CD8+CD25highFOXP3+ (C) cells and to FOXP3 MFI in
CD4+CD25highFOXP3+ (B) and CD8+CD25highFOXP3+ (D) cells. Unpaired two-tailed Student t-test, p#0.05 was considered significant. Results are
presented as mean with SD.
doi:10.1371/journal.pone.0079072.g002
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separated into MB and PB, the MB patients showed a greater
frequency of Treg than HHC: CD4+CD25high-
FOXP3+21.9368.43 vs. 13.7968.19% (Figure 2A) and
CD8+CD25highFOXP3+13.8869.17 vs. 6.1865.56% (Figure 2C).
There were no differences between PB patients and HHC in Treg
frequency (Figures 2A and C). In addition, patients had FOXP3
MFI in Treg higher than did HHC (CD4+ Treg, 554.86106.7 vs.
4286129.9, p = 0.0098 and CD8+ Treg, 4906111.2 vs.
371.26134.7, p = 0.0184, data not shown). These differences in
FOXP3 MFI were significant only between MB patients and
HHC (CD4+ Treg, 578.26115.3 vs. 4286129.9, Figure 2B; and
CD8+ Treg, 521.26110.9 vs. 371.26134.7, Figure 2D).
Interestingly, we observed a well-defined population of CD4+/
CD8+CD25highFOXP3high subsets within CD4+ or
CD8+CD25highFOXP3+ cells. When we compared patients versus
HHC, we found no differences between Treg frequencies
(CD4+FOXP3high, 8.2264.50 vs. 5.5764.03%, p = 0.1072 and
CD8+FOXP3high, 3.8163.35 vs. 2.2362.68%, p = 0.1718, data
not shown). MB patients showed a greater CD4+FOXP3high and
CD8+FOXP3high Treg frequency than HHC, 10.3365.69 vs.
5.5764.03% (Figure 3A) and 5.3664.17 vs. 2.2362.68%
(Figure 3C), respectively.
Furthermore, FOXP3 expression levels in CD4+FOXP3high
Treg population were greater in patients (10766140) than in
HHC (879.26193.3), p = 0.0057 (data not shown), especially in
MB patients (10986141.7) (Figure 3B). However, FOXP3 MFI in
CD8+FOXP3high Treg were not different between patients
(10296213.8) and HHC, (870.56220.9), p = 0.0651 (data not
shown), but MB patients Treg tended to have higher FOXP3 MFI
(10886223.5) than HHC (Figure 3D).
Between PB and MB patients we did not find significant
differences in Treg frequency, although it could have tended to be
higher in MB patients if a larger number of subjects had been
evaluated (Figures 2 and 3).
Different Profiles in the Frequency of CD4+/
CD8+CD25+FOXP32 and CD4+/CD8+CD252FOXP32 were
found between Patients and Contacts
We observed that the percentages of CD4+ and
CD8+CD25+FOXP32 cells were greater in patients than in
HHC (CD4+CD25+, 45.57612.65 vs. 29.13617.79%, p = 0.0107
and CD8+CD25+, 46.47613.74 vs. 26.82620.30%, p = 0.0072,
data not shown), especially in PB patients (CD4+CD25+,
49.0766.48% and CD8+CD25+, 48.1466.93%, figures 4A and
B). Furthermore, the percentages of CD4+ and
CD8+CD252FOXP32 cells were lower in patients than in HHC
(CD4+CD252, 32.37613.05 vs. 52.51621.64%, p = 0.0079 and
CD8+CD252, 39.88615.45 vs. 63.59623.15%, p = 0.0046, data
not shown). For the CD4+CD252FOXP32 population, this
difference was evident between PB patients (31.5363.81%) and
HHC (Figure 4C). Regarding CD8+CD252FOXP32 cells, both
PB (38.45621.09%) and MB (41.368.672%) patients showed a
lower frequency of these cells than HHC (Figure 4D).
We also correlated Treg populations with CD4+ or
CD8+CD25+FOXP32 cell frequency. There was no correlation
Figure 3. CD4+/CD8+CD25highFOXP3high cell frequency and FOXP3 mean fluorescence intensity (MFI) in leprosy patients and
contacts. The frequency of Treg in CD4+ or CD8+ lymphocyte gate after 72-hour culture of peripheral blood mononuclear cells with anti-CD3 and
anti-CD28 associated with total sonicated fraction of M. leprae. Comparison between household contacts (HHC), multibacillary patients (MB P) and
paucibacillary patients (PB P), with regard to frequency of CD4+CD25highFOXP3high (A) and CD8+CD25highFOXP3high (C) cells and to FOXP3 MFI in
CD4+CD25highFOXP3high (B) and CD8+CD25highFOXP3high (D) cells. Unpaired two-tailed Student t-test, p#0.05 was considered significant. Results are
presented as mean with SD.
doi:10.1371/journal.pone.0079072.g003
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in patients, but in HHC there was a positive correlation between
all Treg and those subsets’ frequencies (data not shown).
We also evaluated the CD3+CD4+ and CD3+CD8+ lymphocyte
frequencies, but did not observe differences between patients and
HHC or among PB patients, MB patients and HHC (data not
shown).
Treg Frequency is Correlated with the Number of Lesions
and Bacillary Index in Patients
There was a strong positive correlation between CD4+/
CD8+CD25highFOXP3+ Treg frequency and the bacillary index,
as illustrated in Figures 5A and 5B, respectively. They were also
correlated with lesion numbers (Figures 5C and 5D). CD4+/
CD8+CD25highFOXP3high Treg also were positively correlated
with the bacillary index (CD4+, r = 0.7617; p = 0.004 and CD8+,
r = 0.7654; p = 0.0037, data not shown) and also with lesion
numbers (CD4+, r = 0.7899; p = 0.0022 and CD8+, r = 0.93;
p,0.0001, data not shown).
We did not find a correlation between CD4+ or
CD8+CD25+FOXP32 cell frequency and those variables, lesion
numbers and bacillary index, which may indicate that these
subsets are not directly responsible for the inflammatory state in
MB patients.
Discussion
This is the first work investigating CD4+ and CD8+ Treg in
leprosy patients and HHC under 15 years old. Although it has
been many years since the existence of a suppressor population
was described in patients with leprosy [20,30], there is still
controversy over its role in the emergence of the disease and the
different clinical presentations.
Macrophage activation is an important step for M. leprae
infection control. Progression to multibacillary leprosy is charac-
terized by a state of T cell hyporesponsiveness, with consequent
loss of the macrophages’ microbicidal capacity [31]. In this study,
we showed that in individuals under 15 years old, the numbers of
CD4+CD25highFOXP3+ cells and their activated fraction,
CD4+CD25highFOXP3high cells, were higher in MB leprosy
patients compared to HHC.
Our results are similar to those of Palermo et al., who found in
lepromatous patients an increased frequency of
CD4+CD25+FOXP3+ population after culture with M. leprae cell
wall antigens (MLCwA) and increased expression of negative
regulatory molecules in lesion biopsies [32]. However, the
population analyzed included activated cells without regulatory
function, which can express CD25+ and FOXP3+ at lower levels
than Treg [14,33].
Atia et al. detected a greater frequency of CD4+CD25high-
FOXP3+ population in ex-vivo samples of adult patients with the
tuberculoid form of leprosy when compared to controls [34].
However, the gating strategy used by those authors to define
CD25high differed from ours, and they did not examine other Treg
populations, such as CD8+ Treg and CD25highFOXP3high Treg,
which can explain the discrepant results at least in part.
Figure 4. CD4+/CD8+CD25+FOXP32 and CD4+/CD8+CD252FOXP32 frequency in leprosy patients and contacts. The frequency of CD4+/
CD8+CD25+FOXP32 and CD4+/CD8+CD252FOXP32 cells in CD4+ or CD8+ lymphocyte gate after 72-hour culture of peripheral blood mononuclear
cells with anti-CD3 and anti-CD28 associated with total sonicated fraction of M. leprae. Comparison between household contacts (HHC), multibacillary
patients (MB P) and paucibacillary patients (PB P), with regard to frequency of CD4+CD25+FOXP32 (A), CD8+CD25+FOXP32 (B), CD4+CD252FOXP32
(C) and CD8+CD252FOXP32 (D) cells. Unpaired two-tailed Student t-test, p#0.05 was considered significant. Results are presented as mean with SD.
doi:10.1371/journal.pone.0079072.g004
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Massone et al. evaluated Treg in biopsies of leprosy patients
with different clinical forms and demonstrated an increased
frequency of FOXP3+ cells only in patients with reversal reaction
[35]. In that study, the authors used only FOXP3 as a marker for
Treg identification in a small number of patients, which made it
difficult to obtain significant results with non-reaction lepromatous
patients.
CD8+ T cells, called suppressors, were initially identified in the
lesions of patients with lepromatous leprosy, and were found to be
capable of suppressing the response of PBMC to concanavalin A
stimulation [21]. Clones of CD8+ T cells isolated from peripheral
blood of patients with lepromatous leprosy inhibited the activation
of PBMC by M. leprae antigens in vitro [22]. In this study, we
showed for the first time an increased frequency of
CD8+CD25highFOXP3+ and CD8+CD25highFOXP3high cells in
MB patients compared to HHC. We believe that these cells may
be those with suppressive capacity observed in these previous
studies.
Although we did not use other activation markers beyond
CD25, we believe that CD25+FOXP32 cells are activated/effector
T cells in their majority, as demonstrated by Miyara et al. Those
authors demonstrated that the fraction CD25+FOXP32, isolated
from human peripheral blood, did not have suppressor function
and instead enhanced the responder proliferation [15]. The higher
CD4+/CD8+CD25+FOXP32 cell frequency in PB patients
observed in our study may reflect immune activation and cell-
mediated immune response in those patients, as described by
Scollard et al. [7]. We believe that CD4+/CD8+CD25+FOXP32
cells in HHC may counterregulate Treg subsets, as suggested by
the positive correlation between them, maintaining homeostasis
and preventing the disease.
In addition, we observed a greater FOXP3 expression (MFI) by
the CD4+ and CD8+ Treg in MB patients than in HHC. Although
the suppressive potential of Treg and the relation with FOXP3
expression has not been investigated in leprosy, the FOXP3
expression was more related with Treg suppressive potential than
the Treg frequency in mice [36]. In humans, FOXP3 MFI also
was related with suppression mediated by Treg in the autoimmune
disease model [37].
It is not clear how Treg expand in M. leprae infection, but it is
known that pathogens can modulate the immune system in favor
of their survival [10]. It is speculated that lipids of mycobacterial
origin may have a regulatory function. Mannose-capped lipoar-
abinomannan, a glycolipid expressed by M. tuberculosis and M.
leprae [38], is able to expand Treg cells in healthy tuberculin
reactors [39]. Phenolic glycolipid-1 (PGL-1), a specific antigen of
M. leprae, may also have immunosuppressive properties [7].
Furthermore, in skin biopsies, lepromatous leprosy patients
showed a higher number of indoleamine 2,3-dioxygenase (IDO)-
positive cells than borderline tuberculoid patients, and M. leprae
increased the IDO expression in PBMC of healthy controls [40].
IDO is an enzyme that can suppress effector T cells by degrading
tryptophan and by inducing Treg cells [41]. These factors suggest
that components of M. leprae can modulate the immune response
through induction of Treg, which agrees with our finding of a
positive correlation between Treg frequency and bacillary index
on the one hand and the number of lesions in patients on the
other.
Figure 5. Correlation between CD4+/CD8+CD25highFOXP3+ cells and bacillary index and lesion numbers in leprosy patients. The
frequency of CD4+/CD8+CD25highFOXP3+ cells in CD4+ or CD8+ lymphocyte gate was obtained after 72-hour culture of peripheral blood mononuclear
cells with anti-CD3 and anti-CD28 associated with total sonicated fraction of M. leprae. Correlation between bacillary index of leprosy patients and
CD4+CD25highFOXP3 (A) and CD8+CD25highFOXP3 (B) Treg frequency. Correlation between lesion numbers in leprosy patients and
CD4+CD25highFOXP3 (C) and CD8+CD25highFOXP3 (D) cell frequency. Pearson test, p#0.05 was considered significant.
doi:10.1371/journal.pone.0079072.g005
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One limitation of our study was the small sample size for each
clinical form. A larger number of MB and PB patients would help
show differences between these groups and might corroborate that
PB patients have similar Treg frequency as contacts. Another
important question is that PBMC expansion using non-specific
stimuli could reflect Treg which are not involved directly in
leprosy immunopathogenesis. However, stimulation with anti-
CD3 and anti-CD28 is widely used for Treg expansion in the
literature [42–44]. Moreover our finding of a positive correlation
between Treg and patients’ lesion number and bacillary index
suggests that the Treg frequency found is linked to M. leprae
infection.
To verify the functional activity of Treg in leprosy and their
main suppression mechanisms, it is necessary to conduct further
research with adult patients, since those assays need a larger blood
volume.
Our results allow us to speculate that infection by M. leprae can
modulate the immune response, with the induction of Treg, for
creation of a favorable environment for its survival. A follow-up
study of the contacts to monitor the occurrence of illness and
changes in Treg frequency is important to define these cells as a
biomarker of leprosy.
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